February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...
February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...
February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...
February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...
February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...
February 7, 2024 — Eleven scientists leading the way in stroke research will be recognized during the American Stroke ...
February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...
February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...
February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
February 2, 2024 — The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care ...
February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...